One of the films hurt most from the COVID-19 pandemic was No Time To Die. The film faced multiple date shifts and despite the delay, the film did quite well at the box office. No Time to Die eclipsed $730 million in global ticket sales, making the James Bond sequel both the year’s highest-grossing Hollywood film and the top performing film at the box office since COVID-19 .
Despite the box office receipts, the film cost more than $250 million to produce, at least $100 million to promote and tens of millions more to postpone over 16 months. Variety reports that the film needs to make closer to $900 million to break even. As a result, the film now stands to lose $100 million in its theatrical run, according to sources close to production. Other industry sources suggest the losses wouldn’t quite reach the nine-figure mark though they would still be substantial.
